Krajina: Malta
Jazyk: angličtina
Zdroj: Medicines Authority
ESOMEPRAZOLE
Bristol Laboratories Limited
A02BC05
ESOMEPRAZOLE
GASTRO-RESISTANT TABLET
ESOMEPRAZOLE 40 milligram(s)
POM
DRUGS FOR ACID RELATED DISORDERS
Authorised
2014-11-10
Page 1 of 9 PACKAGE LEAFLET: INFORMATION FOR THE PATIENT ESOMEPRAZOLE BRISTOL LABS 20 MG GASTRO-RESISTANT TABLETS ESOMEPRAZOLE BRISTOL LABS 40 MG GASTRO-RESISTANT TABLETS Esomeprazole READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Esomeprazole is and what it is used for 2. What you need to know before you take Esomeprazole 3. How to take this Esomeprazole 4. Possible side effects 5. How to store Esomeprazole 6. Contents of the pack and other information 1. WHAT ESOMEPRAZOLE IS AND WHAT IT IS USED FOR The name of your medicine is Esomeprazole Gastro-Resistant Tablets. This belongs to a group of medicines called ‘proton pump inhibitors’. They work by reducing the amount of acid that your stomach produces. Esomeprazole is used to treat the following conditions: ADULTS AND ADOLESCENTS AGED 12 YEARS AND OVER ‘Gastro-oesophageal reflux disease’ (GORD). This is where acid from the stomach escapes into the gullet (the tube which connects your throat to your stomach) causing pain, inflammation and heartburn. Ulcers in the stomach or upper part of the gut (intestine) that are infected with bacteria called ‘_Helicobacter _ _pylori’_. If you have this condition, your doctor may also prescribe antibiotics to treat the infection and allow the ulcer to heal. ADULTS Stomach ulcers caused by medicines called NSAIDs (Non-Steroidal Anti- Inflammatory Drugs). This medicine can also be used to stop stomach ulcers from forming if you are taking NSAIDs. Page 2 of 9 Too much acid in the sto Prečítajte si celý dokument
Page 1 of 18 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Esomeprazole Bristol Labs 20 mg Gastro-Resistant Tablets Esomeprazole Bristol Labs 40 mg Gastro-Resistant Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each gastro-resistant tablet contains 20 mg of esomeprazole (as magnesium dihydrate). Excipients with known effect: Each gastro-resistant tablet contains sucrose 8.74 mg and lactose monohydrate approximately 37.35 mg. Each gastro-resistant tablet contains 40 mg of esomeprazole (as magnesium dihydrate). Excipients with known effect: Each gastro-resistant tablet contains sucrose 17.48 mg and lactose monohydrate approximately 74.70 mg. For the full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Gastro-resistant tablet (tablet) Light pink colored oval shaped, bevel edged tablets debossed with ‘H’ on one side and ‘186’ on the other side. The tablet dimensions are 14.2mm x 7.1mm. Pink colored oval shaped, bevel edged tablets debossed with ‘H’ on one side and ‘187’ on the other side. The tablet dimensions are 16.2mm x 8.1mm. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Adults Esomeprazole tablets are indicated in adults for: GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) - treatment of erosive reflux oesophagitis - long-term management of patients with healed oesophagitis to prevent relapse - symptomatic treatment of gastro-oesophageal reflux disease (GORD) IN COMBINATION WITH AN APPROPRIATE ANTIBACTERIAL THERAPEUTIC REGIMEN FOR THE ERADICATION OF _HELICOBACTER PYLORI_ AND - healing of _Helicobacter pylori_ associated duodenal ulcer and Page 2 of 18 - prevention of relapse of peptic ulcers in patients with _ Helicobacter pylori_ associated ulcers. PATIENTS REQUIRING CONTINUED NSAID THERAPY -healing of gastric ulcers associated with NSAID therapy. -prevention of gastric and duodenal ulcers associated with NSAID therapy, in patients at risk. PROLONGED TREATMENT AFTER I.V. INDUCED PREVENTION OF REBLEEDING OF PEPTIC ULCERS TREATMENT OF ZOLLINGER Prečítajte si celý dokument